Prevalence and clinical characteristics of the metabolic syndrome in middle-aged Korean adults

Korean Journal of Internal Medicine

Volumn 20, Issue 4, 2005, Pages 310-316

  Hyuk, Sang Kwon ^a   Yong, Moon Park ^a   Hye, Jung Lee ^a   Jin, Hee Lee ^a   Yoon, Hee Choi ^a   Seung, Hyun Ko ^a   Jung, Min Lee ^a   Sung, Rae Kim ^a   So, Young Kang ^a   Won, Chul Lee ^a   Myung, Sook Ahn ^b   Jae, Hong Noh ^b   Jin, Mo Kang ^b   Dong, Suk Kim ^b   Kun, Ho Yoon ^a   Bong, Yun Cha ^a   Kwang, Woo Lee ^a   Sung, Koo Kang ^a   Ho, Young Son ^a,c  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Chungju Health Center   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Metabolic syndrome; Prevalence

Indexed keywords

ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; RANDOM SAMPLE; RISK FACTOR; WORLD HEALTH ORGANIZATION; KOREA; MIDDLE AGED;

ADULT; AGE DISTRIBUTION; AGED; FEMALE; HUMANS; KOREA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE;

EID: 33645815077     PISSN: 12263303     EISSN: None     Source Type: Journal    
DOI: 10.3904/kjim.2005.20.4.310     Document Type: Article

References (27)

1. Reaven GM. Role of insulin resistance in human disease. Annu Rev Med 44:121-131, 1994
2. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible lor NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
3. Albert KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: part 1. diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
4. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NECP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
5. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287:356-359, 2002
6. Cameron AJ, Chaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 33:351-375, 2004
7. Ramachandran A, Snehalatha C, Satyavani K, Sivasnakari S, Vijay V. Metabolic syndrome in urban Asian Indian adults: a population study using modified ATP III criteria. Diabetes Res Clin Pract 60:199-204, 2003
8. Lee WY, Park JS, Noh SY, Rhee EJ, Kim SW, Zimmet PZ. Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res Clin Pract 65:143-149, 2004
9. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 16:157-177, 1993
10. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. Diabet Med 16:442-443, 1999
11. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM, Neufeld ND, Petak SM, Rodbard HW, Seibel JA, Smith DA, Wilson PW. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9:237-252, 2002
12. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults: a population study using modified ATP III criteria. Diabetes Res Clin Pract 60:199-204, 2003
13. World Health Organization Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157-163, 2004
14. Tan CE, Chew SK, Ma S, Tai ES, Wai D. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 27:1182-1186, 2004
15. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382-386, 1991
16. Wang J, Thornton JC, Russell M, Burastero S, Heymsfield S, Pierson RN Jr. Asians have lower body mass index (BMI) but higher percentage body fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr 60:23-28, 1994
17. Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat percent relationship. Obes Rev 3:141-146, 2002
18. WHO/IASO/IOTF The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications Australia Pty Ltd, 2000
19. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT. Testosterone and sex hormone binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27:1036-1041, 2004
20. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88:2404-2411, 2003
21. Joffe B, Zimmet P. The thrifty genotype in type 2 diabetes: an unfinished symphony moving to its finale? Endocrine 9:139-141, 1998
22. Lev-Ran A. Human obesity an evolutionary approach to understanding our bulging waistline. Diabetes Metab Res Rev 17:347-362, 2001
23. Olefsky JM, Farquhar JW, Reaven GM. Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 57:551-560, 1974
24. Garg A. Insulinn resistance in the pathogenesis of dyslipidemia. Diabetes Care 19:387-389, 1996
25. Chang SA, Kim HS, Yoon KH, Ko SH, Kwon HS, Kim SR, Lee WC, Yoo SJ, Son HS, Cha BY, Lee KW, Son HY, Kang SK. Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea. Metabolism 53:142-146, 2004
26. Haffner SM. Pre-diabetes, insulin resitance, inflammation and CVD risk Diabetes Res Clin Pract 61(Suppl 1):S9-S18, 2003
27. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 89:2569-2575, 2004